Company Description

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States.

It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.

The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

iCAD, Inc.

Country	United States
Founded	1984
IPO Date	Dec 3, 1986
Industry	Medical Devices
Sector	Healthcare
Employees	69
CEO	Dana Brown

Contact Details

Address: 98 Spit Brook Road, Suite 100 Nashua, New Hampshire 03062 United States
Phone	603 882 5200
Website	icadmed.com

Stock Details

Ticker Symbol	ICAD
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0000749660
CUSIP Number	44934S206
ISIN Number	US44934S2068
Employer ID	02-0377419
SIC Code	3841

Key Executives

Name	Position
Dana R. Brown	President, Chief Executive Officer and Executive Chair
Eric Lonnqvist	Chief Financial Officer
Jonathan Go	Chief Technology Officer
Michelle Strong	Chief Operations Officer
Annette L. Heroux	Vice President of Administration
Brian Testa	Chief People Officer
Bill Keyes	Senior Vice President of Global Sales Operations
Vasu Avadhanula	Chief Product Officer
Peter Graham	Senior Vice President of North American Sales

Latest SEC Filings

Date	Type	Title
Aug 14, 2024	10-Q/A	[Amend] Quarterly report
Aug 14, 2024	10-Q	Quarterly Report
Aug 13, 2024	8-K	Current Report
Jul 2, 2024	S-8	Securities to be offered to employees in employee benefit plans
Jun 14, 2024	8-K	Current Report
May 15, 2024	8-K	Current Report
May 15, 2024	10-Q	Quarterly Report
Apr 29, 2024	DEF 14A	Other definitive proxy statements
Mar 29, 2024	10-K	Annual Report
Mar 12, 2024	8-K	Current Report

View All SEC Filings